S 476 · 118th Congress
Maintaining Investments in New Innovation Act
<p><b>Maintaining Investments in New Innovation Act</b></p> <p>This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Se…
- Sponsor
- Menendez, Robert (D-NJ)
- Introduced
- 2023-02-16
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Finance.
Digging through Congress... 🔍